{"gene":"ATP9A","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2016,"finding":"ATP9A localizes to phosphatidylserine-positive early and recycling endosomes (but not late endosomes) in HeLa cells, and its depletion delays transferrin recycling from endosomes to the plasma membrane and causes accumulation of glucose transporter 1 in endosomes, without affecting EGF degradation or Shiga toxin B transport to the Golgi.","method":"Fluorescence localization, siRNA knockdown, transferrin recycling assay, GLUT1 trafficking assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — clean KD with multiple specific cargo readouts, replicated across cargo types","pmids":["27733620"],"is_preprint":false},{"year":2018,"finding":"ATP9A forms an evolutionarily conserved endosome-associated complex with MON2 and DOPEY2; SNX3-retromer associates with this complex, and the complex is required for Wntless endosome-to-Golgi sorting and Wnt secretion. ATPase-dead ATP9A (TAT-5 E246Q) causes Wnt phenotype, implicating phospholipid flippase activity in SNX3-retromer-mediated cargo sorting.","method":"Co-immunoprecipitation, mass spectrometry, in vivo C. elegans genetics (RNAi), ATPase-dead mutant overexpression","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP/MS plus in vivo genetic epistasis and ATPase-dead mutant, cross-species validation","pmids":["30213940"],"is_preprint":false},{"year":2019,"finding":"Knockdown of ATP9A in human hepatoma cells significantly increases extracellular vesicle (exosome) release in a caspase-3-independent manner; pharmacological blockade of exosome release reduces this increase, defining ATP9A as a regulator of exosome secretion.","method":"siRNA knockdown, nanoparticle tracking analysis of EVs, pharmacological inhibition of exosome release","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined EV phenotype, single lab","pmids":["30947313"],"is_preprint":false},{"year":2023,"finding":"ATP9A localizes predominantly to endosomes and modulates RAB5 and RAB11 GTPase activation to control the endosomal recycling pathway; pathogenic truncating mutants show aberrant subcellular localization and cause abnormal endosomal recycling, impaired neurite morphology, and synaptic transmission defects in Atp9a null mice.","method":"Atp9a null mouse model, primary neuron culture, RAB5/RAB11 activity assays (GTP-bound pulldown), subcellular fractionation/localization, synaptic electrophysiology","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO model with multiple orthogonal readouts plus biochemical RAB activity assays","pmids":["36604604"],"is_preprint":false},{"year":2023,"finding":"ATP9A interacts with ATP6V1A (V-ATPase subunit) and facilitates its transport to the plasma membrane, promoting plasma membrane cholesterol accumulation and driving RAC1-dependent macropinocytosis in hepatocellular carcinoma cells under nutrient starvation.","method":"Co-immunoprecipitation, confocal localization, cholesterol staining, RAC1 activity assay, macropinocytosis assays, siRNA knockdown","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and functional assays, single lab, moderate mechanistic depth","pmids":["36715683"],"is_preprint":false},{"year":2025,"finding":"ATP9A and ATP9B form homomeric and heteromeric complexes; both proteins are located in the TGN and together mediate VSVG transport from the Golgi to the plasma membrane in the exocytic pathway; flippase activity of both is required for this transport; heteromeric complex formation retains ATP9A in the Golgi.","method":"Co-immunoprecipitation, VSVG transport assay, flippase-dead mutants, fluorescence localization","journal":"Life science alliance","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, cargo transport assay with flippase-dead mutants, multiple orthogonal approaches","pmids":["40234049"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures of human monomeric ATP9A at 2.2 Å resolution in the E2P state reveal a unique outward gating mechanism driven by movement of TM6-10 helices (initiated by TM6 unwinding), distinct from canonical TM1-2/A-domain gating; the enlarged phospholipid-binding cavity can accommodate lipids with larger headgroups than phosphatidylserine. ATPase activity is significantly stimulated by negatively charged phospholipids (PS, PI, phosphoinositides) but not electroneutral lipids. ATP9A functions as a monomer and does not require CDC50.","method":"Cryo-EM structure determination (2.2 Å), in vitro ATPase activity assay with defined phospholipids, molecular dynamics simulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with in vitro biochemical validation and MD simulation","pmids":["40876594"],"is_preprint":false},{"year":2025,"finding":"Overexpression of missense mutant forms of ATP9A in HeLa cells and primary neuronal cultures causes loss of mature dendritic spines; shRNA knockdown of ATP9A decreases neuronal arborization and dendrite number, demonstrating ATP9A is required for dendritic spine maturation and neuronal morphology.","method":"Overexpression of missense mutants in HeLa cells and primary neurons, shRNA knockdown, dendritic spine/morphology quantification","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — functional cellular assay with loss-of-function and gain-of-function, single lab","pmids":["40226306"],"is_preprint":false},{"year":2025,"finding":"In yeast, ATP9A ortholog Neo1 flips PI4P from the luminal to cytosolic leaflet in the Golgi; knockdown of human ATP9A exposes extracellular PI4P at the plasma membrane, demonstrating that ATP9A maintains phosphoinositide membrane asymmetry and controls neomycin sensitivity.","method":"Yeast Neo1 mutant genetics, cryo-EM of Neo1 with PI4P, human cell ATP9A knockdown, PI4P extracellular exposure assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 — cryo-EM of yeast ortholog with substrate, human cell KD with PI4P readout; preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.03.03.641220"],"is_preprint":true},{"year":2024,"finding":"In C. elegans, gain-of-function mutations in TAT-5 (ATP9A ortholog) and its associated Dopey protein PAD-1 reduce extracellular vesicle release and restore neuronal morphology in dip-2 sax-2 double mutants; PAD-1(gf) acts cell-autonomously in neurons and shows increased plasma membrane association, placing TAT-5/ATP9A in a DIP-2/SAX-2/PAD-1/TAT-5 network that maintains neuronal morphology.","method":"C. elegans genetics (suppressor screen, gain-of-function alleles), extracellular vesicle quantification, cell-autonomy mosaic analysis, fluorescence localization","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in vivo with EV quantification; preprint, ortholog in C. elegans","pmids":["bio_10.1101_2024.05.07.591898"],"is_preprint":true}],"current_model":"ATP9A is a CDC50-independent monomeric P4-ATPase (lipid flippase) that localizes to early/recycling endosomes and the TGN, where it uses a unique TM6-10 gating mechanism to translocate negatively charged phospholipids (including PS and phosphoinositides) to the cytoplasmic leaflet; it maintains membrane asymmetry, drives endosomal recycling to the plasma membrane by modulating RAB5/RAB11 activity, participates in an MON2–DOPEY2–ATP9A complex that supports SNX3-retromer-mediated Wntless sorting, forms homomeric/heteromeric complexes with ATP9B to facilitate Golgi-to-plasma-membrane exocytic transport, suppresses exosome release, and is required for dendritic spine maturation and neuronal morphology maintenance."},"narrative":{"teleology":[{"year":2016,"claim":"Establishing where ATP9A acts and its first cellular function: ATP9A was shown to reside on PS-positive early/recycling endosomes and to be required for recycling cargo back to the plasma membrane, linking a class-5 P4-ATPase to a specific membrane trafficking step.","evidence":"siRNA knockdown in HeLa cells with transferrin recycling and GLUT1 trafficking assays","pmids":["27733620"],"confidence":"High","gaps":["Whether ATP9A flippase activity is directly required for the recycling phenotype was not tested","Mechanism by which ATP9A promotes recycling (direct lipid flipping vs. effector recruitment) was unknown"]},{"year":2018,"claim":"Identifying ATP9A's protein complex and a role in retrograde sorting: ATP9A was found to form an endosomal complex with MON2 and DOPEY2, which collaborates with SNX3-retromer to sort Wntless, connecting ATP9A flippase activity to a specific cargo sorting pathway required for Wnt secretion.","evidence":"Reciprocal co-IP/MS, C. elegans RNAi epistasis, and ATPase-dead mutant phenocopy","pmids":["30213940"],"confidence":"High","gaps":["Direct biochemical demonstration of lipid flipping by ATP9A was still lacking","How flippase-generated membrane asymmetry mechanistically promotes SNX3-retromer tubule formation was not resolved"]},{"year":2019,"claim":"Extending ATP9A function to extracellular vesicle biogenesis: loss of ATP9A was shown to increase exosome release, establishing ATP9A as a negative regulator of EV secretion independently of caspase-3.","evidence":"siRNA knockdown in hepatoma cells with nanoparticle tracking analysis of EVs","pmids":["30947313"],"confidence":"Medium","gaps":["Single lab observation; independent confirmation in other cell types was not reported","Whether the exosome phenotype is a direct consequence of altered lipid asymmetry or secondary to recycling defects was unresolved"]},{"year":2023,"claim":"Revealing ATP9A's mechanism in endosomal recycling and its neuronal importance: ATP9A was demonstrated to control RAB5/RAB11 GTPase activation at endosomes, and Atp9a-null mice exhibited impaired neurite morphology and synaptic transmission, establishing a physiological requirement in the nervous system.","evidence":"Atp9a knockout mouse, RAB5/RAB11 GTP-pulldown assays, primary neuron culture, synaptic electrophysiology","pmids":["36604604"],"confidence":"High","gaps":["Whether ATP9A directly activates or inhibits RAB GEFs/GAPs was not determined","The specific phospholipid substrates mediating the neuronal phenotype were unknown"]},{"year":2023,"claim":"Linking ATP9A to nutrient scavenging: ATP9A was found to interact with V-ATPase subunit ATP6V1A and promote its delivery to the plasma membrane, driving cholesterol accumulation and RAC1-dependent macropinocytosis under nutrient stress in hepatocellular carcinoma cells.","evidence":"Co-IP, confocal imaging, cholesterol staining, RAC1 activity assay in HCC cells","pmids":["36715683"],"confidence":"Medium","gaps":["Single lab study in one cancer cell type; generalizability unclear","Whether the ATP6V1A interaction depends on ATP9A flippase activity was not tested"]},{"year":2025,"claim":"Defining ATP9A's role in the exocytic pathway: ATP9A and ATP9B were shown to form homomeric and heteromeric complexes at the TGN, and flippase activity of both was required for VSVG transport from Golgi to the plasma membrane, establishing a new role for ATP9A beyond endosomal recycling.","evidence":"Reciprocal co-IP, VSVG transport assay with flippase-dead mutants, fluorescence localization","pmids":["40234049"],"confidence":"High","gaps":["The stoichiometry and structure of the ATP9A–ATP9B heteromeric complex are unknown","Whether the heteromeric complex has distinct substrate specificity from homomers was not addressed"]},{"year":2025,"claim":"Solving the structural basis of ATP9A catalysis: cryo-EM at 2.2 Å revealed ATP9A operates as a CDC50-independent monomer with a novel outward gating mechanism (TM6–10 movement) and an enlarged lipid-binding cavity that accommodates substrates beyond PS, including phosphoinositides.","evidence":"Cryo-EM structure determination, in vitro ATPase assays with defined lipid substrates, molecular dynamics simulations","pmids":["40876594"],"confidence":"High","gaps":["Structure was captured only in the E2P state; conformational cycle intermediates (E1, E2) remain unresolved","No structure with a bound phospholipid substrate was obtained"]},{"year":2025,"claim":"Establishing ATP9A's neuronal cell-biological function: missense mutations and shRNA knockdown demonstrated that ATP9A is required for dendritic spine maturation and neuronal arborization, linking its flippase activity to synaptic structure.","evidence":"Overexpression of missense mutants and shRNA knockdown in HeLa cells and primary neurons with spine/morphology quantification","pmids":["40226306"],"confidence":"Medium","gaps":["Single lab study; the specific lipid substrate changes underlying spine defects are unknown","Whether dendritic spine defects are cell-autonomous was not definitively established in mammalian neurons"]},{"year":null,"claim":"Key open questions: the full conformational cycle of ATP9A during lipid translocation remains structurally unresolved; the mechanism by which flippase-driven lipid asymmetry activates RAB GTPases or promotes membrane tubulation for cargo sorting is unknown; whether ATP9A loss-of-function mutations cause a defined human neurological disorder has not been established through human genetic studies.","evidence":"","pmids":[],"confidence":"High","gaps":["No substrate-bound structural intermediate has been captured","The link between lipid flipping and RAB GEF/GAP regulation is mechanistically unresolved","Human disease causality from ATP9A mutations has not been demonstrated in family studies"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[6,8]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[5]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,3,5]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,7]}],"complexes":["MON2–DOPEY2–ATP9A","ATP9A–ATP9B heteromer"],"partners":["MON2","DOPEY2","ATP9B","ATP6V1A","SNX3"],"other_free_text":[]},"mechanistic_narrative":"ATP9A is a CDC50-independent P4-ATPase lipid flippase that translocates negatively charged phospholipids—including phosphatidylserine and phosphoinositides—from the exoplasmic to the cytoplasmic membrane leaflet, thereby maintaining phospholipid asymmetry at endosomes and the trans-Golgi network [PMID:40876594, PMID:27733620]. At early and recycling endosomes, ATP9A modulates RAB5 and RAB11 GTPase activation to drive endosomal recycling of cargo such as transferrin receptor and GLUT1 to the plasma membrane, and participates in an evolutionarily conserved MON2–DOPEY2 complex that supports SNX3-retromer-mediated Wntless sorting and Wnt secretion [PMID:27733620, PMID:36604604, PMID:30213940]. ATP9A also forms homomeric and heteromeric complexes with ATP9B at the TGN to facilitate Golgi-to-plasma-membrane exocytic transport, suppresses exosome release, and is required for dendritic spine maturation and neuronal morphology, with loss-of-function mutations causing synaptic transmission defects in mice [PMID:40234049, PMID:30947313, PMID:36604604, PMID:40226306]. High-resolution cryo-EM reveals that ATP9A operates as a monomer with a unique outward-open gating mechanism driven by TM6–10 helix rearrangement, distinct from the canonical TM1-2/A-domain gate of other P4-ATPases, and possesses an enlarged cavity capable of accommodating lipids with headgroups larger than phosphatidylserine [PMID:40876594]."},"prefetch_data":{"uniprot":{"accession":"O75110","full_name":"Probable phospholipid-transporting ATPase IIA","aliases":["ATPase class II type 9A"],"length_aa":1047,"mass_kda":118.6,"function":"Plays a role in regulating membrane trafficking of cargo proteins, namely endosome to plasma membrane recycling, probably acting through RAB5 and RAB11 activation (PubMed:27733620, PubMed:30213940, PubMed:36604604). Also involved in endosome to trans-Golgi network retrograde transport (PubMed:27733620, PubMed:30213940). In complex with MON2 and DOP1B, regulates SNX3 retromer-mediated endosomal sorting of WLS, a transporter of Wnt morphogens in developing tissues. Participates in the formation of endosomal carriers that direct WLS trafficking back to Golgi, away from lysosomal degradation (PubMed:30213940). Appears to be implicated in intercellular communication by negatively regulating the release of exosomes (PubMed:30947313). The flippase activity towards membrane lipids and its role in membrane asymmetry remains to be proved (PubMed:30947313). Required for the maintenance of neurite morphology and synaptic transmission (By similarity)","subcellular_location":"Early endosome membrane; Recycling endosome membrane; Late endosome membrane; Golgi apparatus, trans-Golgi network membrane; Cell membrane","url":"https://www.uniprot.org/uniprotkb/O75110/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP9A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"STX12","stoichiometry":0.2},{"gene":"VAMP3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ATP9A","total_profiled":1310},"omim":[{"mim_id":"620242","title":"NEURODEVELOPMENTAL DISORDER WITH POOR GROWTH AND BEHAVIORAL ABNORMALITIES; NEDGBA","url":"https://www.omim.org/entry/620242"},{"mim_id":"614446","title":"ATPase, CLASS II, TYPE 9B; ATP9B","url":"https://www.omim.org/entry/614446"},{"mim_id":"609126","title":"ATPase, CLASS II, TYPE 9A; ATP9A","url":"https://www.omim.org/entry/609126"},{"mim_id":"605868","title":"ATPase, PHOSPHOLIPID TRANSPORTING, 11A; ATP11A","url":"https://www.omim.org/entry/605868"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":87.5}],"url":"https://www.proteinatlas.org/search/ATP9A"},"hgnc":{"alias_symbol":["KIAA0611","ATPIIA"],"prev_symbol":[]},"alphafold":{"accession":"O75110","domains":[{"cath_id":"2.70.150.10","chopping":"156-286","consensus_level":"high","plddt":87.0191,"start":156,"end":286},{"cath_id":"-","chopping":"343-368_826-1045","consensus_level":"high","plddt":87.9726,"start":343,"end":1045},{"cath_id":"3.40.50.1000","chopping":"388-397_658-819","consensus_level":"high","plddt":89.2391,"start":388,"end":819},{"cath_id":"3.40.1110.10","chopping":"400-429_451-474_493-653","consensus_level":"high","plddt":88.6182,"start":400,"end":653},{"cath_id":"1.10.287","chopping":"68-135","consensus_level":"high","plddt":85.2456,"start":68,"end":135}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75110","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75110-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75110-F1-predicted_aligned_error_v6.png","plddt_mean":84.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP9A","jax_strain_url":"https://www.jax.org/strain/search?query=ATP9A"},"sequence":{"accession":"O75110","fasta_url":"https://rest.uniprot.org/uniprotkb/O75110.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75110/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75110"}},"corpus_meta":[{"pmid":"30213940","id":"PMC_30213940","title":"SNX3-retromer requires an evolutionary conserved MON2:DOPEY2:ATP9A complex to mediate Wntless sorting and Wnt secretion.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30213940","citation_count":69,"is_preprint":false},{"pmid":"27733620","id":"PMC_27733620","title":"The phospholipid flippase ATP9A is required for the recycling pathway from the endosomes to the plasma membrane.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/27733620","citation_count":55,"is_preprint":false},{"pmid":"30947313","id":"PMC_30947313","title":"The P4-ATPase ATP9A is a novel determinant of exosome release.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30947313","citation_count":31,"is_preprint":false},{"pmid":"36604604","id":"PMC_36604604","title":"ATP9A deficiency causes ADHD and aberrant endosomal recycling via modulating RAB5 and RAB11 activity.","date":"2023","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36604604","citation_count":21,"is_preprint":false},{"pmid":"34379057","id":"PMC_34379057","title":"Biallelic truncating variants in ATP9A cause a novel neurodevelopmental disorder involving postnatal microcephaly and failure to thrive.","date":"2021","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34379057","citation_count":19,"is_preprint":false},{"pmid":"36715683","id":"PMC_36715683","title":"The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma.","date":"2023","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/36715683","citation_count":10,"is_preprint":false},{"pmid":"40234049","id":"PMC_40234049","title":"Lipid flippases ATP9A and ATP9B form a complex and contribute to the exocytic pathway from the Golgi.","date":"2025","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/40234049","citation_count":4,"is_preprint":false},{"pmid":"39832103","id":"PMC_39832103","title":"Circular RNA ATP9A Stimulates Non-small Cell Lung Cancer Progression via MicroRNA-582-3p/Ribosomal Protein Large P0 Axis and Activating Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway.","date":"2025","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39832103","citation_count":3,"is_preprint":false},{"pmid":"40226306","id":"PMC_40226306","title":"Heterozygous Missense Variants in the ATPase Phospholipid Transporting 9A Gene, ATP9A, Alter Dendritic Spine Maturation and Cause Dominantly Inherited Nonsyndromic Intellectual Disability.","date":"2025","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/40226306","citation_count":1,"is_preprint":false},{"pmid":"39871218","id":"PMC_39871218","title":"Integration of Mendelian Randomization to explore the genetic influences of pediatric sepsis: a focus on RGL4, ATP9A, MAP3K7CL, and DDX11L2.","date":"2025","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/39871218","citation_count":1,"is_preprint":false},{"pmid":"40876594","id":"PMC_40876594","title":"A unique gating mechanism revealed by the cryo-EM structure of monomeric ATP9A flippase.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40876594","citation_count":0,"is_preprint":false},{"pmid":"41581045","id":"PMC_41581045","title":"Identification of ATP9A-NFATC2 gene fusion transcript in Behcet's disease, a subtype of uveitis.","date":"2026","source":"Indian journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/41581045","citation_count":0,"is_preprint":false},{"pmid":"41604004","id":"PMC_41604004","title":"The role of ATP9A (c.1091G > C; p.(Arg364Thr)) variant in cognitive impairment: diagnostic insight from whole exome sequencing.","date":"2026","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/41604004","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.03.641220","title":"P4-ATPase control over phosphoinositide membrane asymmetry and neomycin resistance","date":"2025-03-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.03.641220","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.13.623339","title":"Lipid flippases ATP9A and ATP9B form a complex and contribute to the secretory pathway from the Golgi apparatus","date":"2024-11-15","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.13.623339","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.07.591898","title":"Dopey-dependent regulation of extracellular vesicles maintains neuronal morphology","date":"2024-05-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.07.591898","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9650,"output_tokens":2580,"usd":0.033825},"stage2":{"model":"claude-opus-4-6","input_tokens":5899,"output_tokens":2631,"usd":0.142905},"total_usd":0.17673,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP9A localizes to phosphatidylserine-positive early and recycling endosomes (but not late endosomes) in HeLa cells, and its depletion delays transferrin recycling from endosomes to the plasma membrane and causes accumulation of glucose transporter 1 in endosomes, without affecting EGF degradation or Shiga toxin B transport to the Golgi.\",\n      \"method\": \"Fluorescence localization, siRNA knockdown, transferrin recycling assay, GLUT1 trafficking assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple specific cargo readouts, replicated across cargo types\",\n      \"pmids\": [\"27733620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ATP9A forms an evolutionarily conserved endosome-associated complex with MON2 and DOPEY2; SNX3-retromer associates with this complex, and the complex is required for Wntless endosome-to-Golgi sorting and Wnt secretion. ATPase-dead ATP9A (TAT-5 E246Q) causes Wnt phenotype, implicating phospholipid flippase activity in SNX3-retromer-mediated cargo sorting.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, in vivo C. elegans genetics (RNAi), ATPase-dead mutant overexpression\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP/MS plus in vivo genetic epistasis and ATPase-dead mutant, cross-species validation\",\n      \"pmids\": [\"30213940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Knockdown of ATP9A in human hepatoma cells significantly increases extracellular vesicle (exosome) release in a caspase-3-independent manner; pharmacological blockade of exosome release reduces this increase, defining ATP9A as a regulator of exosome secretion.\",\n      \"method\": \"siRNA knockdown, nanoparticle tracking analysis of EVs, pharmacological inhibition of exosome release\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined EV phenotype, single lab\",\n      \"pmids\": [\"30947313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ATP9A localizes predominantly to endosomes and modulates RAB5 and RAB11 GTPase activation to control the endosomal recycling pathway; pathogenic truncating mutants show aberrant subcellular localization and cause abnormal endosomal recycling, impaired neurite morphology, and synaptic transmission defects in Atp9a null mice.\",\n      \"method\": \"Atp9a null mouse model, primary neuron culture, RAB5/RAB11 activity assays (GTP-bound pulldown), subcellular fractionation/localization, synaptic electrophysiology\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO model with multiple orthogonal readouts plus biochemical RAB activity assays\",\n      \"pmids\": [\"36604604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ATP9A interacts with ATP6V1A (V-ATPase subunit) and facilitates its transport to the plasma membrane, promoting plasma membrane cholesterol accumulation and driving RAC1-dependent macropinocytosis in hepatocellular carcinoma cells under nutrient starvation.\",\n      \"method\": \"Co-immunoprecipitation, confocal localization, cholesterol staining, RAC1 activity assay, macropinocytosis assays, siRNA knockdown\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and functional assays, single lab, moderate mechanistic depth\",\n      \"pmids\": [\"36715683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ATP9A and ATP9B form homomeric and heteromeric complexes; both proteins are located in the TGN and together mediate VSVG transport from the Golgi to the plasma membrane in the exocytic pathway; flippase activity of both is required for this transport; heteromeric complex formation retains ATP9A in the Golgi.\",\n      \"method\": \"Co-immunoprecipitation, VSVG transport assay, flippase-dead mutants, fluorescence localization\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, cargo transport assay with flippase-dead mutants, multiple orthogonal approaches\",\n      \"pmids\": [\"40234049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of human monomeric ATP9A at 2.2 Å resolution in the E2P state reveal a unique outward gating mechanism driven by movement of TM6-10 helices (initiated by TM6 unwinding), distinct from canonical TM1-2/A-domain gating; the enlarged phospholipid-binding cavity can accommodate lipids with larger headgroups than phosphatidylserine. ATPase activity is significantly stimulated by negatively charged phospholipids (PS, PI, phosphoinositides) but not electroneutral lipids. ATP9A functions as a monomer and does not require CDC50.\",\n      \"method\": \"Cryo-EM structure determination (2.2 Å), in vitro ATPase activity assay with defined phospholipids, molecular dynamics simulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with in vitro biochemical validation and MD simulation\",\n      \"pmids\": [\"40876594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Overexpression of missense mutant forms of ATP9A in HeLa cells and primary neuronal cultures causes loss of mature dendritic spines; shRNA knockdown of ATP9A decreases neuronal arborization and dendrite number, demonstrating ATP9A is required for dendritic spine maturation and neuronal morphology.\",\n      \"method\": \"Overexpression of missense mutants in HeLa cells and primary neurons, shRNA knockdown, dendritic spine/morphology quantification\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cellular assay with loss-of-function and gain-of-function, single lab\",\n      \"pmids\": [\"40226306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In yeast, ATP9A ortholog Neo1 flips PI4P from the luminal to cytosolic leaflet in the Golgi; knockdown of human ATP9A exposes extracellular PI4P at the plasma membrane, demonstrating that ATP9A maintains phosphoinositide membrane asymmetry and controls neomycin sensitivity.\",\n      \"method\": \"Yeast Neo1 mutant genetics, cryo-EM of Neo1 with PI4P, human cell ATP9A knockdown, PI4P extracellular exposure assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — cryo-EM of yeast ortholog with substrate, human cell KD with PI4P readout; preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.03.03.641220\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In C. elegans, gain-of-function mutations in TAT-5 (ATP9A ortholog) and its associated Dopey protein PAD-1 reduce extracellular vesicle release and restore neuronal morphology in dip-2 sax-2 double mutants; PAD-1(gf) acts cell-autonomously in neurons and shows increased plasma membrane association, placing TAT-5/ATP9A in a DIP-2/SAX-2/PAD-1/TAT-5 network that maintains neuronal morphology.\",\n      \"method\": \"C. elegans genetics (suppressor screen, gain-of-function alleles), extracellular vesicle quantification, cell-autonomy mosaic analysis, fluorescence localization\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with EV quantification; preprint, ortholog in C. elegans\",\n      \"pmids\": [\"bio_10.1101_2024.05.07.591898\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ATP9A is a CDC50-independent monomeric P4-ATPase (lipid flippase) that localizes to early/recycling endosomes and the TGN, where it uses a unique TM6-10 gating mechanism to translocate negatively charged phospholipids (including PS and phosphoinositides) to the cytoplasmic leaflet; it maintains membrane asymmetry, drives endosomal recycling to the plasma membrane by modulating RAB5/RAB11 activity, participates in an MON2–DOPEY2–ATP9A complex that supports SNX3-retromer-mediated Wntless sorting, forms homomeric/heteromeric complexes with ATP9B to facilitate Golgi-to-plasma-membrane exocytic transport, suppresses exosome release, and is required for dendritic spine maturation and neuronal morphology maintenance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP9A is a CDC50-independent P4-ATPase lipid flippase that translocates negatively charged phospholipids—including phosphatidylserine and phosphoinositides—from the exoplasmic to the cytoplasmic membrane leaflet, thereby maintaining phospholipid asymmetry at endosomes and the trans-Golgi network [PMID:40876594, PMID:27733620]. At early and recycling endosomes, ATP9A modulates RAB5 and RAB11 GTPase activation to drive endosomal recycling of cargo such as transferrin receptor and GLUT1 to the plasma membrane, and participates in an evolutionarily conserved MON2–DOPEY2 complex that supports SNX3-retromer-mediated Wntless sorting and Wnt secretion [PMID:27733620, PMID:36604604, PMID:30213940]. ATP9A also forms homomeric and heteromeric complexes with ATP9B at the TGN to facilitate Golgi-to-plasma-membrane exocytic transport, suppresses exosome release, and is required for dendritic spine maturation and neuronal morphology, with loss-of-function mutations causing synaptic transmission defects in mice [PMID:40234049, PMID:30947313, PMID:36604604, PMID:40226306]. High-resolution cryo-EM reveals that ATP9A operates as a monomer with a unique outward-open gating mechanism driven by TM6–10 helix rearrangement, distinct from the canonical TM1-2/A-domain gate of other P4-ATPases, and possesses an enlarged cavity capable of accommodating lipids with headgroups larger than phosphatidylserine [PMID:40876594].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing where ATP9A acts and its first cellular function: ATP9A was shown to reside on PS-positive early/recycling endosomes and to be required for recycling cargo back to the plasma membrane, linking a class-5 P4-ATPase to a specific membrane trafficking step.\",\n      \"evidence\": \"siRNA knockdown in HeLa cells with transferrin recycling and GLUT1 trafficking assays\",\n      \"pmids\": [\"27733620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ATP9A flippase activity is directly required for the recycling phenotype was not tested\",\n        \"Mechanism by which ATP9A promotes recycling (direct lipid flipping vs. effector recruitment) was unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying ATP9A's protein complex and a role in retrograde sorting: ATP9A was found to form an endosomal complex with MON2 and DOPEY2, which collaborates with SNX3-retromer to sort Wntless, connecting ATP9A flippase activity to a specific cargo sorting pathway required for Wnt secretion.\",\n      \"evidence\": \"Reciprocal co-IP/MS, C. elegans RNAi epistasis, and ATPase-dead mutant phenocopy\",\n      \"pmids\": [\"30213940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct biochemical demonstration of lipid flipping by ATP9A was still lacking\",\n        \"How flippase-generated membrane asymmetry mechanistically promotes SNX3-retromer tubule formation was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extending ATP9A function to extracellular vesicle biogenesis: loss of ATP9A was shown to increase exosome release, establishing ATP9A as a negative regulator of EV secretion independently of caspase-3.\",\n      \"evidence\": \"siRNA knockdown in hepatoma cells with nanoparticle tracking analysis of EVs\",\n      \"pmids\": [\"30947313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab observation; independent confirmation in other cell types was not reported\",\n        \"Whether the exosome phenotype is a direct consequence of altered lipid asymmetry or secondary to recycling defects was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealing ATP9A's mechanism in endosomal recycling and its neuronal importance: ATP9A was demonstrated to control RAB5/RAB11 GTPase activation at endosomes, and Atp9a-null mice exhibited impaired neurite morphology and synaptic transmission, establishing a physiological requirement in the nervous system.\",\n      \"evidence\": \"Atp9a knockout mouse, RAB5/RAB11 GTP-pulldown assays, primary neuron culture, synaptic electrophysiology\",\n      \"pmids\": [\"36604604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether ATP9A directly activates or inhibits RAB GEFs/GAPs was not determined\",\n        \"The specific phospholipid substrates mediating the neuronal phenotype were unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linking ATP9A to nutrient scavenging: ATP9A was found to interact with V-ATPase subunit ATP6V1A and promote its delivery to the plasma membrane, driving cholesterol accumulation and RAC1-dependent macropinocytosis under nutrient stress in hepatocellular carcinoma cells.\",\n      \"evidence\": \"Co-IP, confocal imaging, cholesterol staining, RAC1 activity assay in HCC cells\",\n      \"pmids\": [\"36715683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab study in one cancer cell type; generalizability unclear\",\n        \"Whether the ATP6V1A interaction depends on ATP9A flippase activity was not tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defining ATP9A's role in the exocytic pathway: ATP9A and ATP9B were shown to form homomeric and heteromeric complexes at the TGN, and flippase activity of both was required for VSVG transport from Golgi to the plasma membrane, establishing a new role for ATP9A beyond endosomal recycling.\",\n      \"evidence\": \"Reciprocal co-IP, VSVG transport assay with flippase-dead mutants, fluorescence localization\",\n      \"pmids\": [\"40234049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The stoichiometry and structure of the ATP9A–ATP9B heteromeric complex are unknown\",\n        \"Whether the heteromeric complex has distinct substrate specificity from homomers was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Solving the structural basis of ATP9A catalysis: cryo-EM at 2.2 Å revealed ATP9A operates as a CDC50-independent monomer with a novel outward gating mechanism (TM6–10 movement) and an enlarged lipid-binding cavity that accommodates substrates beyond PS, including phosphoinositides.\",\n      \"evidence\": \"Cryo-EM structure determination, in vitro ATPase assays with defined lipid substrates, molecular dynamics simulations\",\n      \"pmids\": [\"40876594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure was captured only in the E2P state; conformational cycle intermediates (E1, E2) remain unresolved\",\n        \"No structure with a bound phospholipid substrate was obtained\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Establishing ATP9A's neuronal cell-biological function: missense mutations and shRNA knockdown demonstrated that ATP9A is required for dendritic spine maturation and neuronal arborization, linking its flippase activity to synaptic structure.\",\n      \"evidence\": \"Overexpression of missense mutants and shRNA knockdown in HeLa cells and primary neurons with spine/morphology quantification\",\n      \"pmids\": [\"40226306\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab study; the specific lipid substrate changes underlying spine defects are unknown\",\n        \"Whether dendritic spine defects are cell-autonomous was not definitively established in mammalian neurons\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions: the full conformational cycle of ATP9A during lipid translocation remains structurally unresolved; the mechanism by which flippase-driven lipid asymmetry activates RAB GTPases or promotes membrane tubulation for cargo sorting is unknown; whether ATP9A loss-of-function mutations cause a defined human neurological disorder has not been established through human genetic studies.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No substrate-bound structural intermediate has been captured\",\n        \"The link between lipid flipping and RAB GEF/GAP regulation is mechanistically unresolved\",\n        \"Human disease causality from ATP9A mutations has not been demonstrated in family studies\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 3, 5]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"complexes\": [\n      \"MON2–DOPEY2–ATP9A\",\n      \"ATP9A–ATP9B heteromer\"\n    ],\n    \"partners\": [\n      \"MON2\",\n      \"DOPEY2\",\n      \"ATP9B\",\n      \"ATP6V1A\",\n      \"SNX3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}